Janssen Pharmaceutica N.v., Belgium
Clinical trials sponsored by Janssen Pharmaceutica N.v., Belgium, explained in plain language.
-
Real-World study tracks how long psoriatic arthritis patients stay on newer biologics
Disease control OngoingThis study follows over 1,300 people with psoriatic arthritis to see how long they continue taking guselkumab or IL-17 inhibitor medications in routine care. Researchers will track joint swelling and tenderness, and record when patients start and stop these drugs. The goal is to …
Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated May 26, 2026 09:05 UTC
-
New drug combo may delay prostate cancer spread in High-Risk patients
Disease control OngoingThis study tests whether adding the drug apalutamide to standard radiation and hormone therapy can delay cancer spread or death in men with high-risk prostate cancer that has not yet spread. About 692 participants are involved. The approach uses advanced imaging (PSMA-PET) to tra…
Phase: PHASE3 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated May 26, 2026 09:05 UTC
-
New vaccine aims to halt Alzheimer's before symptoms start
Disease control OngoingThis study tests an experimental vaccine (JNJ-64042056) designed to help the immune system target and clear a harmful protein called tau in the brain. The goal is to slow or stop the spread of tau, which is linked to Alzheimer's disease. The trial includes 55 people with early si…
Phase: PHASE2 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated May 26, 2026 09:02 UTC